top of page
yellow infected cells.png
2405 2904 Y4F_logo_landscape_white_RGB.png

Deconstructing the protective immunity of yellow fever virus 17D to inform flavivirus vaccine design

 
haut de page
institutpasteur_i04434.jpg

Yellow4FLAVI at a glance

5 Years

2024 -2028

Budget 8M

Funded by the EU

Horizon Europe

12 Partners & 1 Affiliated Entity

In 7 Countries

6 EU and Colombia

32 Tasks

Distributed in 8 WPs

6 Clinical Studies

conducted by 4 Partners

50 Experts

virologists, cell biologists, immunologists, computational scientists, clinicians, social scientists

2405 2907 Y4F_monogram device_blue_RGB.png

Milestones

19 Milestones

Deliverables

58 Delivrables

Consortium

Yellow4FLAVI, coordinated by Dr. Giovanna Barba-Spaeth at the Institut Pasteur in Paris, relies on unprecedented transnational and transdisciplinary collaboration, bringing together academic institutions, research centers, and internationally renowned experts.

 

We are molecular and structural virologists, cell biologists, immunologists, computational scientists, clinicians, and social scientists assembled in a tight collaborative network.

​

Each partner brings unique expertise, enriching our understanding of flaviviruses and the development of innovative vaccination strategies.

2405 2907 Y4F_monogram device_white_RGB_
logo_ip_header.png
Logo_LMU.png
AIGHD_logo_011217.png
Uniklinikum-Erlangen.png
new_logo_IZS_135px.png
Sans titre.png
logo-inserm-60ans.png
logo.png
logo-UNIPD-white.png
charite.png
01-ImmuneWatch-POS-horizontal-pictwordmark-e1652710459543-1536x397.png
logo-cideim.gif

About the project

While endemic to the tropics, flaviviruses like Zika, dengue, West Nile or yellow fever virus are re-emerging pathogens of global health concern.

Climate change and urbanization have largely contributed to the dissemination of their mosquito vector and Europe has in recent years been regularly confronted with autochthonous cases.

 

Few vaccines are licensed to prevent flavivirus disease, but the yellow fever 17D (YF17D) vaccine has a unique track record of efficiency and safety. Intriguingly, despite its success, how YF17D induces immunity remains poorly understood.

YELLOW4FLAVI aims to fill the gaps in our understanding of the mechanism of action of this vaccine by linking the structure of the viral particle to the resulting host immune response, in order to learn about optimal vaccine design for flaviviruses in general.

 

Since social acceptance of vaccines is critical for their success, we will also develop optimal communication methods. This will provide us with the tools to tailor vaccine design not only to achieve optimal immune protection, but also to facilitate actual implementation.

institutpasteur_66262.jpg
2405 2906 Y4F_portrait shield_blue_RGB.png
bottom of page